iMMCO Diagnostics
Stage
Loan | AliveTotal Raised
$1.5MLast Raised
$1.5M | 3 yrs agoAbout iMMCO Diagnostics
IMMCO Diagnostics provides high-quality diagnostic test kits and lab testing services worldwide for the screening of autoimmune disorders. IMMCO Diagnostics incorporates working on research, clinical laboratory expertise, and medical devices into an approach to autoimmune diagnostics.
Missing: iMMCO Diagnostics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: iMMCO Diagnostics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing iMMCO Diagnostics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
iMMCO Diagnostics is included in 2 Expert Collections, including Medical Devices.
Medical Devices
11,721 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,901 items
iMMCO Diagnostics Patents
iMMCO Diagnostics has filed 5 patents.
The 3 most popular patent topics include:
- ATC codes
- Autoantibodies
- Autoimmune diseases
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/24/2015 | 10/22/2019 | Autoimmune diseases, Transcription factors, Immunologic tests, Molecular biology, Proteins | Grant |
Application Date | 3/24/2015 |
|---|---|
Grant Date | 10/22/2019 |
Title | |
Related Topics | Autoimmune diseases, Transcription factors, Immunologic tests, Molecular biology, Proteins |
Status | Grant |
Latest iMMCO Diagnostics News
Dec 17, 2017
Summary IMMCO Diagnostics Inc IMMCO, a subsidiary of Trinity Biotech Plc is a biotechnology company that offers autoimmune disease diagnostic solutions. The company offers a wide range of IFAs, EIAs, Line Immunoassays and Western Blots for an extensive variety of autoimmune disorders. It also develops and manufactures a comprehensive portfolio of assays and instrumentation for autoimmune diseases. IMMCO offers biopsy, serology and other test services. The company provides test services for the diagnosis of autoimmune disorders and related immunological conditions such as Sjogren's syndrome, thyroiditis, rheumatoid arthritis and others. IMMCO is headquartered in Buffalo, New York, the US. Immco Diagnostics Inc Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News
iMMCO Diagnostics Frequently Asked Questions (FAQ)
Where is iMMCO Diagnostics's headquarters?
iMMCO Diagnostics's headquarters is located at 60 Pineview Drive, Buffalo.
What is iMMCO Diagnostics's latest funding round?
iMMCO Diagnostics's latest funding round is Loan.
How much did iMMCO Diagnostics raise?
iMMCO Diagnostics raised a total of $1.5M.
Who are the investors of iMMCO Diagnostics?
Investors of iMMCO Diagnostics include Paycheck Protection Program and Summit Partners.
Who are iMMCO Diagnostics's competitors?
Competitors of iMMCO Diagnostics include Affidea, SFC Fluidics, Mirabilis, Foundation Medicine, ContraVac, Minomic International, Celula, T2 Biosystems, Ulthera, Crescendo Bioscience and 13 more.
Compare iMMCO Diagnostics to Competitors
PalindromX Limited (PdX) specialises in developing in vitro diagnostic (IVD) technologies. It is most active in the fields of super-sensitive, multiplexed immunoassay technology, DNA-based vaccination techniques and bone resorption testing services. PdX has generated an intellectual property portfolio in a two areas that is expected to proceed to grant, providing a potentially lucrative future royalty stream. Super sensitive, multiplexed immunoassay; DNA vaccination; bone resorption testing PalindromX Limited (UK) Bone Resorption Services PdX offers a custom in vitro bone resorption testing service to the pharmaceutical, biotechnology and research communities.
Lifelinelab s.r.l. started its activities in April 2003, thanks to the commitment of three managers coming from the ex Diagnostic Division Manufacturing Plant of Alfa Wassermann S.P.A. First step has been to secure raw materials, and equipment for R&D and Manufacturing of products and services in the field of Human in Vitro Diagnostics. nnnnnFirst diagnostic reagents were manufactured, in this site, over 40 years ago, through the bravery and the enterprising spirit of Prof. Balducci ex Managing Director of Virology Laboratory of "Istituto Superiore di Sanitu00e0". First products were based on tissue colture technology included a line of complement fixation antigens. Since then, the company developed methods and products, covering almost all the fields of Human in Vitro Diagnostics, from Clinical Chemistry to Immunochemistry. The mostly developed sector has been that of Infectious Diseases with particular regard to Viral pathologies. Most products have been developed using biological raw materials derived from in house, in vivo or in vitro, productions. Nowadays the company aims to face and develop markets with consolidate and emerging technologies such as Microarrays using a chemistry patented and designed to covalently bind either Protein or Nucleic acids which aims to allow the development of extremely sophisticated analysis in the emerging applications of proteomics and genomics.
Clinical Laboratory Partners is a provider of clinical diagnostic testing services for healthcare providers, both hospitals and private practices, effectively competing in local markets against a range of national and other local clinical diagnostic laboratories.
Sentinel Diagnostics is an Italian company with a long and well established background in the development and production of diagnostic kits destined for use in medical analysis laboratories, hospitals, clinics and private health care structures.
GDXI is a provider of telemedical EKG testing and information services, data management and diagnostic services in the home healthcare and other non-hospital environments.
Gold Standard Diagnostics (GSD) provides diagnostic solutions that improve lab efficiency and minimize overall costs. Through an extensive product menu, automated instrument platforms, and outstanding customer service, GSD solves real laboratory problems. The result is a seamless laboratory experience achieved through an integrated approach.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.